Recruiting A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer NCT05733013 Conditions Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +7 more Locations Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
